TREA

97444992 - T T-DETECT

Follow

Information

  • Trademark
  • 97444992
  • Serial Number
    97444992
  • Filing Date
    June 06, 2022
    2 years ago
  • Transaction Date
    October 28, 2024
    2 months ago
  • Status Date
    October 28, 2024
    2 months ago
  • Published for Opposition Date
    August 01, 2023
    a year ago
  • Location Date
    September 26, 2023
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    OSBORNE, AUDRIANA
  • Attorney Docket Number
    10214-2-048
    Attorney Name
    Hoang-chi Truong
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
3
Mark Identification
T T-DETECT
Case File Statements
  • DM0000: The mark consists of the design of 3 stylized ovals with one on top and two horizontally below with the space between them forming a stylized letter "T" and the stylized wording "T-Detect" to the right of the design.
  • GS0051: Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use , namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical diagnostic and prognostic testing services; providing medical immunosequencing-based diagnostic and prognostic testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services relating to the diagnosis and treatment of persons
  • GS0421: Providing information about medical research in the field medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples
Case File Event Statements
  • 6/9/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/15/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/16/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 3/20/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/22/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/22/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/22/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/22/2023 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/22/2023 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/23/2023 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/12/2023 - a year ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/1/2023 - a year ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/27/2023 - a year ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/1/2023 - a year ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/26/2023 - a year ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/22/2024 - 9 months ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 3/22/2024 - 9 months ago
    16 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 3/23/2024 - 9 months ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/28/2024 - 2 months ago
    20 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 10/28/2024 - 2 months ago
    21 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 3/22/2024 - 9 months ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G